The Patent Finder

Yangtze River Pharmaceutical Group Co., Ltd.

Also on record
Records under this name other than the patents Yangtze River Pharmaceutical Group Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.

Back to Yangtze River Pharmaceutical Group Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,696,228Oral preparation of dyclonine hydrochloride
Term ended
Term ended Jun 16, 2026 · USPTO record
Term endedTerm ended Jun 16, 2026USPTO record
US 9,890,1682,4-disubstituted 7H-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medicinal use thereof
Lapsed on the fee record
Ended Feb 13, 2026 · USPTO record
Lapsed on the fee recordEnded Feb 13, 2026USPTO record
US 9,879,0082,3,4,6-tetra-substituted benzene-1,5-diamine derivatives, preparation method therefor and medicinal use thereof
Lapsed on the fee record
Ended Jan 30, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 30, 2026USPTO record
US 7,745,4332-Substituted phenyl-5, 7-dihydrocarbyl-3, 7-dihydropyrrolo [2, 3-D] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
Term ended
Term ended Dec 30, 2025 · USPTO record
Term endedTerm ended Dec 30, 2025USPTO record
US 11,174,254Aniline-substituted 1,2-dihydropyrrol[3,4-C]pyridin/pyrimidin-3-one derivative and use thereof
Lapsed on the fee record
Ended Nov 16, 2025 · USPTO record
Lapsed on the fee recordEnded Nov 16, 2025USPTO record
US 11,168,088Pyridylamino substituted heterotricyclic compounds, and preparation method and pharmaceutical use thereof
Lapsed on the fee record
Ended Nov 9, 2025 · USPTO record
Lapsed on the fee recordEnded Nov 9, 2025USPTO record
US 11,155,5464,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivatives and uses thereof
Lapsed on the fee record
Ended Oct 26, 2025 · USPTO record
Lapsed on the fee recordEnded Oct 26, 2025USPTO record
US 11,104,6644,5,6-trisubstituted indazole derivatives, and preparation method and pharmaceutical use thereof
Lapsed on the fee record
Ended Aug 31, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 31, 2025USPTO record
US 8,461,1652-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
Lapsed on the fee record
Ended Jun 11, 2025 · USPTO record
Lapsed on the fee recordEnded Jun 11, 2025USPTO record
US 10,947,202Sodium ion channel inhibitors and pharmaceutically acceptable salts and polymorphs thereof and uses thereof
Lapsed on the fee record
Ended Mar 16, 2025 · USPTO record
Lapsed on the fee recordEnded Mar 16, 2025USPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited